Molecular actors of the Calcium signaling in the endothelial-to-mesenchymal transition: poorly explored therapeutic targets
Cell Calcium · 2026-07 · 136 · 103163
DOI: 10.1016/j.ceca.2026.103163 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Calcium, 2026-07. Verfasst von Romain Guinamard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Université Caen Normandie, PSIR UR4650, Cyceron, F-14000, Caen, France. Electronic address: romain.guinamard@unicaen.fr. Hauptthemen laut MEDLINE: Endothelial-Mesenchymal Transition, Calcium Signaling. Die Arbeit nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ANR.
Abstract (Originalsprache)
Endothelial-to-mesenchymal transition (EndMT) is a cell trans-differentiation process which occurs during embryonic development as well as in a variety of pathological contexts. During this process, cells lose their endothelial lineage markers and gain mesenchymal ones. It is stimulated by several factors, such as TGF-β, high glucose, or hypoxia, which trigger intracellular pathways, mainly the Smad and ERK pathways, leading to modulation of transcription factors. While Ca2+ signaling is known to participate in a wide variety of cellular processes, its role in the context of EndMT is only partially understood, although several Ca2+-carrying and Ca2+-regulated proteins have been shown to influence EndMT. These include Ca2+-permeable channels from the mechanosensitive Piezo family and members of the TRP family; the actors involved in store-operated Ca2+ entry, including IP3-receptors located on the endoplasmic reticulum membrane, the endoplasmic reticulum Ca2+ sensor STIM1, and the Ca2+-permeable plasma membrane channel Orai1; the mitochondrial Ca2+uniporter complex; Ca2+-activated channels such as the non-selective monovalent cation channel TRPM4 and the big-conductance K+ channel BKCa; Ca2+-regulated signaling pathways such as the Ca2+-calmodulin-calcineurin-NFAT pathway and the calpain-ERK pathway. After a brief description of Ca2+ signaling in endothelial cells, this review will specifically detail the available data on the Ca2+ signaling in EndMT. Links between Ca2+ signaling and other signaling pathways leading to EndMT will be discussed. Finally, molecular targets that may be valuable to explore in order to prevent EndMT will be highlighted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Caen Normandie, PSIR UR4650, Cyceron, F-14000, Caen, France. Electronic address: romain.guinamard@unicaen.fr.
- Université Caen Normandie, PSIR UR4650, Cyceron, F-14000, Caen, France.
- Université Rouen Normandie, Inserm, EnVI UMR1096, F-76000, Rouen, France.
Förderung
- ANR
Zitieren
APA
Guinamard, R., Kerevel, C., Darengosse, A., Platel, V., Sallé, L., & Simard, C. (2026). Molecular actors of the Calcium signaling in the endothelial-to-mesenchymal transition: poorly explored therapeutic targets. Cell Calcium, 136, 103163. https://doi.org/10.1016/j.ceca.2026.103163
Vancouver
Guinamard R, Kerevel C, Darengosse A, Platel V, Sallé L, Simard C. Molecular actors of the Calcium signaling in the endothelial-to-mesenchymal transition: poorly explored therapeutic targets. Cell Calcium. 2026;136:103163. doi:10.1016/j.ceca.2026.103163
BibTeX
@article{Guinamard2026,
author = {Guinamard, Romain and Kerevel, Corentin and Darengosse, Anaïs and Platel, Valentin and Sallé, Laurent and Simard, Christophe},
title = {Molecular actors of the Calcium signaling in the endothelial-to-mesenchymal transition: poorly explored therapeutic targets},
journal = {Cell Calcium},
year = {2026},
volume = {136},
pages = {103163},
doi = {10.1016/j.ceca.2026.103163}
}
EUVIMED